ONCOTYPE DXI
DEAD

Serial Number

88126037

Owner

Genomic Health, Inc.

Attorney

Mark A. Steiner

Filing Date

Sep 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ONCOTYPE DXI Trademark

Serial Number: 88126037

ONCOTYPE DXI is a trademark filed by Genomic Health, Inc. on September 20, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Genomic Health, Inc. (72 trademarks)

301 Penobscot Drive
Redwood City, CA 94063

Entity Type: 03

Trademark Details

Filing Date

September 20, 2018

Registration Date

Not Registered

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 13, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 13, 2019 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 16, 2019 GNFN
FINAL REFUSAL E-MAILED
Apr 16, 2019 GNFR
FINAL REFUSAL WRITTEN
Apr 16, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2019 CRFA
ASSIGNED TO LIE
Apr 8, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 7, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 7, 2019 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 3, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 3, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 3, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 2, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2018 NWOS
NEW APPLICATION ENTERED
Sep 24, 2018 NWAP